307 related articles for article (PubMed ID: 24850731)
1. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.
Iwata-Yoshikawa N; Uda A; Suzuki T; Tsunetsugu-Yokota Y; Sato Y; Morikawa S; Tashiro M; Sata T; Hasegawa H; Nagata N
J Virol; 2014 Aug; 88(15):8597-614. PubMed ID: 24850731
[TBL] [Abstract][Full Text] [Related]
2. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
[TBL] [Abstract][Full Text] [Related]
3. Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.
Sekimukai H; Iwata-Yoshikawa N; Fukushi S; Tani H; Kataoka M; Suzuki T; Hasegawa H; Niikura K; Arai K; Nagata N
Microbiol Immunol; 2020 Jan; 64(1):33-51. PubMed ID: 31692019
[TBL] [Abstract][Full Text] [Related]
4. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.
Tseng CT; Sbrana E; Iwata-Yoshikawa N; Newman PC; Garron T; Atmar RL; Peters CJ; Couch RB
PLoS One; 2012; 7(4):e35421. PubMed ID: 22536382
[TBL] [Abstract][Full Text] [Related]
5. Formalin-treated UV-inactivated SARS coronavirus vaccine retains its immunogenicity and promotes Th2-type immune responses.
Tsunetsugu-Yokota Y; Ato M; Takahashi Y; Hashimoto S; Kaji T; Kuraoka M; Yamamoto K; Mitsuki YY; Yamamoto T; Oshima M; Ohnishi K; Takemori T
Jpn J Infect Dis; 2007 May; 60(2-3):106-12. PubMed ID: 17515642
[TBL] [Abstract][Full Text] [Related]
6. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.
Bolles M; Deming D; Long K; Agnihothram S; Whitmore A; Ferris M; Funkhouser W; Gralinski L; Totura A; Heise M; Baric RS
J Virol; 2011 Dec; 85(23):12201-15. PubMed ID: 21937658
[TBL] [Abstract][Full Text] [Related]
7. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine.
Roberts A; Lamirande EW; Vogel L; Baras B; Goossens G; Knott I; Chen J; Ward JM; Vassilev V; Subbarao K
Viral Immunol; 2010 Oct; 23(5):509-19. PubMed ID: 20883165
[TBL] [Abstract][Full Text] [Related]
9. Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.
Yasui F; Kai C; Kitabatake M; Inoue S; Yoneda M; Yokochi S; Kase R; Sekiguchi S; Morita K; Hishima T; Suzuki H; Karamatsu K; Yasutomi Y; Shida H; Kidokoro M; Mizuno K; Matsushima K; Kohara M
J Immunol; 2008 Nov; 181(9):6337-48. PubMed ID: 18941225
[TBL] [Abstract][Full Text] [Related]
10. PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV.
Gai WW; Zhang Y; Zhou DH; Chen YQ; Yang JY; Yan HM
Virol Sin; 2011 Apr; 26(2):81-94. PubMed ID: 21468931
[TBL] [Abstract][Full Text] [Related]
11. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.
Spruth M; Kistner O; Savidis-Dacho H; Hitter E; Crowe B; Gerencer M; Brühl P; Grillberger L; Reiter M; Tauer C; Mundt W; Barrett PN
Vaccine; 2006 Jan; 24(5):652-61. PubMed ID: 16214268
[TBL] [Abstract][Full Text] [Related]
12. A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.
Takasuka N; Fujii H; Takahashi Y; Kasai M; Morikawa S; Itamura S; Ishii K; Sakaguchi M; Ohnishi K; Ohshima M; Hashimoto S; Odagiri T; Tashiro M; Yoshikura H; Takemori T; Tsunetsugu-Yokota Y
Int Immunol; 2004 Oct; 16(10):1423-30. PubMed ID: 15314040
[TBL] [Abstract][Full Text] [Related]
13. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
[TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice.
Qu D; Zheng B; Yao X; Guan Y; Yuan ZH; Zhong NS; Lu LW; Xie JP; Wen YM
Vaccine; 2005 Jan; 23(7):924-31. PubMed ID: 15603894
[TBL] [Abstract][Full Text] [Related]
17. Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection
Luan N; Li T; Wang Y; Cao H; Yin X; Lin K; Liu C
Front Immunol; 2022; 13():882856. PubMed ID: 35464483
[TBL] [Abstract][Full Text] [Related]
18. Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus.
Agrawal AS; Tao X; Algaissi A; Garron T; Narayanan K; Peng BH; Couch RB; Tseng CT
Hum Vaccin Immunother; 2016 Sep; 12(9):2351-6. PubMed ID: 27269431
[TBL] [Abstract][Full Text] [Related]
19. Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry.
He Y; Zhou Y; Siddiqui P; Jiang S
Biochem Biophys Res Commun; 2004 Dec; 325(2):445-52. PubMed ID: 15530413
[TBL] [Abstract][Full Text] [Related]
20. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
